DDR1 and cancer: In contrast, DDR1 degraders, by promoting the proteasomal degradation of DDR1, offer a more comprehensive therapeutic strategy, effectively eliminating both its enzymatic and scaffold functions and providing a more potent approach for cancer treatment.